Recent Articles

Medtronic Receives Clearance for the SHILLA Growth Guidance System

| 09/01/2014

Medtronic, Inc., today announced the 510(k) clearance and launch of the SHILLA Growth Guidance System. The system is designed for treatment of skeletally immature pediatric patients less than 10 years of age diagnosed with severe, progressive, life-threatening, early-onset spinal deformities. The SHILLA Growth Guidance System is a new growth-sparing technology that allows correction of the […]

Continue Reading

Less than 40% of people in the UK understand the pathologist’s vital role in diagnosing cancer

| 09/01/2014

As the European Congress of Pathology begins this weekend in London, new research from GE Healthcare shows that many people do not understand the importance of the pathologist in the diagnosis and treatment of breast cancer1, the most common cancer in Europe, with more than 464,000 new cases diagnosed in 2012.2 Pathologists are vital to […]

Continue Reading

Bariatric Surgery Boosts Brain Power

| 09/01/2014

At bariatric facilities like Dr. Feiz and Associates, the life-changing benefits of bariatric surgery, including reduced risk of diabetes, cardiovascular disease and endocrine disorders are well established. After all, Michael Feiz, M.D., F.A.C.S. has successfully treated thousands of patients through bariatric procedures like Lap Band, sleeve gastrectomy and related revision treatments. However, a recent study […]

Continue Reading

This is Your Brain’s Blood Vessels on Drugs

| 08/30/2014

A new method for measuring and imaging how quickly blood flows in the brain could help doctors and researchers better understand how drug abuse affects the brain, which may aid in improving brain-cancer surgery and tissue engineering, and lead to better treatment options for recovering drug addicts. The new method, developed by a team of […]

Continue Reading

Next-Generation Assay Platform Expands Cell Analysis for Life Science Researchers

| 08/30/2014

Life science researchers who want to expand their capabilities beyond traditional cell counting instruments can now do so with the Countess II FL, a next-generation, bench-top assay instrument with a modular design that broadens the number of applications on a single platform. “The most important upgrade is the system’s multiple channel fluorescence capabilities, which would […]

Continue Reading

BioControl Medical Announces INOVATE-HF Study Evaluating CardioFit System in Heart Failure

| 08/30/2014

BioControl Medical announced today that it has reached an important clinical trial milestone, reaching 480 randomized subjects – or 70 percent – of the planned 650 subjects with congestive heart failure (HF) in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) trial of its CardioFit® system, the first medical device designed to treat HF […]

Continue Reading

Carnegie Mellon Launches Global Brain Research Initiative, Leveraging Strengths in Computation and the Brain Sciences

| 08/26/2014

Coalescing its strengths in computer science, neuroscience, psychology and engineering, Carnegie Mellon University today announced the launch of CMU BrainHub(SM), a new initiative focusing on understanding how the structure and activity of the brain give rise to complex behaviors. CMU scientists and their global partners including Sun Yat-sen University in Guangzhou, China; the Indian Institute […]

Continue Reading

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen

| 08/26/2014

Pfizer Inc.  and Merck & Co. Inc., known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizer’s crizotinib (XALKORI®) with Merck’s investigational anti-PD-1 antibody pembrolizumab, in a Phase 1b clinical study evaluating the safety […]

Continue Reading